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1. Introduction 
Mycobacteria [1 ], cell walls from human and non 
human mycobacterial strains [2, 3] as well as myco- 
bacterial waxes D with a nitrogen-containing moiety 
[4, 5] possess a 'Freund's adjuvant effect' [1]; all 
these substances lead also to the production of delayed 
hypersensitivity and of certain disease states uch as 
allergic encephalomyelitis or adjuvant arthritis [5, 6]. 
These different insoluble active fractions of high 
molecular weight contain a polysaccharide (Poly, 
mainly an arabinogalactan [7-9] ) linked to a 
peptidoglycan (PA) [ 10-12]. Poly-PA constitutes 
the hydrosoluble moiety which is joined by ester 
linkages to the lipidic part (Lip, mycolic acids as in 
wax D). Previously we described [13] the preparation 
by a mild extraction technique of a hydrosoluble 
adjuvant-active substance (Poly-PA) from the 
delipidated cells of the human mycobacterial strain 
Peurois which did no more elicit the arthritis inducing 
effect. These studies were achieved quite independent- 
ly from those reported at the same time by others 
[14, 15]; their hydrosoluble polysaccharide fractions 
obtained by different procedures required either the 
preparation of purified cell walls which were further 
submitted to an enzymic digestion or a chemical 
treatment (catalytic hydrogenation) of delipidated 
BCG cells. 
All these adjuvant-active hydrosoluble fractions 
presented a high molecular weight. This note deals 
* 18th Communication mycobacterial adjuvant-active 
substances. 
with the preparation of adjuvant-active fractions of 
low molecular weight. Two types of compounds were 
characterized: a first one where the sugars remained 
unchanged during the preparation steps ('native' type) 
and a second one where the sugars were acetylated. 
2. Methods 
2.1. Mycobacterial residues 
The mycobacterial residues were prepared and their 
lipids eliminated according to Aebi et al. [ 16]. 
2.2. Preparation o f  crude hydrosoluble substances 
2.2.1. 'Native' type 
A first method was previously described [13] 
including homogenization in water and ammonium 
sulfate treatment until 70% saturation: the active 
substance remained in the supernatant ($70). A second 
procedure included apyridine extraction at 28°C during 
24 or 36 hr followed by an addition of alcohol. The 
supematant was dried and hydrosoluble substances 
were extracted by water. 
2.2.2. 'Acetylated' type 
The acetylation of delipidated cells was performed 
as pleviously reported [10, 17, 18] for waxes D. The 
fraction which remained alcohol-sohible was dried and 
submitted to extraction by water. The compounds 
which were soluble in alcohol and water were submitted 
for further purifications. 
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Table 1 
Yield of hydrosoluble extracts obtained from delipidated cells of mycobacterial strains by water extraction (W.E.) and acetylation 
(Ac.). The presence of the peptidoglycan is indicated by the DAP content (%). 
Strain Extraction Temperature Extraction Crude DAP (%) 
procedure (°C) time (hr) extract 
(% of) 'Native' purified extract* Acetylation 
High mol wt. Low mol wt. (crude 













W.E. 20 6 ] 2.6 7.6 
30 18 2.7 J 
Ac. 28 3 1.7 
24 3.0 
72 1.9 
W.E. 20 6 0.9 0.8 
40 76 5.0 0.5 2.4 
Ac. 28 24 2.0 
W.E. 40 48 3.7 1.0 6.0 
Ac. 28 36 4.2 
W.E. 20 5 ] 0.06 
25 18 I 1.2 
Ac. 28 36 0.2 
W.E. 40 18 1.1 0.03 
W.E. 40 18 2.6 0.4 
W.E. 40 24 ] 1.5 





* High and low mol wt.: high and low molecular weight fractions eluted from DEAE-cellulose calculated on the basis of 3 residus 
of Ala/mole (see parts 3.1 and 3.2). 
** Bovine strain containing waxes D with a nitrogen-containing moiety [24]. 
2.3. Purification of  low molecular weight hydrosoluble 
adjuvants 
2.3.1. 'Native' hydrosoluble substances 
The substances soluble in alcohol and in water 
obtained after the pyridine treatment were filtered on 
Biogel P 100 columns (250 × 1.2 cm) with 0.01 N 
acetic acid as eluent. The fractions were monitored at 
220 and 280 nm. The delipidated residues were sub- 
mitted for homogenization a d ammonium sulfate 
treatment [13]. The 'native' hydrosoluble substances 
contained in $70 fractions were dialyzed on Diaflo- 
membranes UM2 (Amicon) with a view to eliminate 
all the compounds with a molecular weight lower than 
1000. They were further chromatographed 
on DEAE-cellulose (Whatman DE 32) equilibrated 
with a 0.05 M phosphate buffer pH 7 and with a 
0.05 M sodium citr'ate buffer pH 3 as eluent. 
2.3.2. Acetylated hydrosoluble substances 
They were also dialyzed on Diaflo-membranes and 
further purified on Biogel P 10 columns (250 × 2 cm) 
with 0.01 N acetic acid as eluent. 
2.4. Characterization f the various constituents 
The amino acid and amino sugar compositions were 
established with an Autoanalyzer after total hydrolysis 
(6 N HC1; 110°C; under vacuum) of 18 hr and 6 hr, 
respectively. The reducing non amino sugars were 
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determined according to Dische [19] and the phos- 
phorous according to Fiske and Subbarow [20]. The 
glycolyl groups were characterized following the pro- 
cedures of Calkins [21] and Eegriwe [22]. 
2.5. Biological activities 
Adjuvant activity was determined according to 
White et al. [4, 5] and the arthrogenicity following 
Bonhomme t al. [23]. 
3. Results 
Only mycobacterial strains from which waxes D 
with a nitrogen containing moiety could be extracted, 
such as human, atypical or certain bovine strains 
[5, 24], gave rise to hydrosoluble substances either by 
homogenization in water or by acetylation (table 1) 
which contained meso<~ ¢~'-diaminopimelic acid (DAP), 
one of the main constituents of PA. 
3.1. 'Native' hydrosoluble substances (adjuvants) 
Some analytical data concerning the hydrosoluble 
substances i olated by the pyridine treatment are 
reported in table 2. Four substances (1-4)  soluble in 
alcohol and containing DAP were characterized on
Biogel P 100. The cell residues were homogenized by wa- 
ter [ 13 ]. The chromatography on DEAE-cellulose of S 70 
fractions isolated from strains Peurois, H37Ra or Test 
gave rise to 8 fractions (!-VI I I ) ;  6 of them (I l l -VI I I )  
contained DAP. Peaks III and IV where previously 
cl~aracterized [13]; they corresponded to various 
Poly-PA with molecular weights ranging from 12 000-  
26 000 on the basis of 3 residues of Ala/mole. The 
substances contained in fractions VI and VII had lower 
tool. wt. (6000-7000). They behaved as adjuvants [25] 
as determined according to White et al. [4, 5] but were 
no more arthrogenic [23]. 
3.2. Acetylated hydrosoluble substances 
Fig. 1 indicates the purification of the crude 
acetylated adjuvant-active [4, 25] hydrosoluble frac- 
tion from strain H37Ra (or Peurois) on Biogel P 10 
and table 3 summarizes some analytical data. Four 
main peaks were characterized. Two of them (1 and 2) 
representing 10% of the crude extract, were more 
particularly studied. Their molecular weights were 
slightly below 4000, on the basis of 3 residues of 
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Fig. 1. Filtration on Biogel P 10 (250 X 2 cm) of the crude aeetylated hydrosoluble extract of mycobacterial cells, strain Ha7Ra; 
0.01 N acetic acid as solvent. 
Ala/mole. Table 3 indicates that these two compounds 
contain principally the peptidoglycan and only small 
amounts of reducing non amino sugars: 13 -+ 2% for 
peak 1, and 11-12% for peak 2 devoid of pentose 
(arabinose). The presence of  glycol groups was charac- 
terized but no phosphorous could be detected. The 
rest of the molecules were constituted by the acetyl 
groups. 
4. Conclusion 
This note describes the purification by various 
methods of hydrosoluble adjuvant-active low molecular 
weight substances from mycobacterial strains. The 
'native' substances contain yet a polysaccharide part, 
whereas the acetylated compounds are mainly con- 
stituted by the peptidoglycan (PA); the latter remain 
Table 3 
Amino acid, amino sugar and reducing non amino sugar compositions (m.r. and %) of different acetylated purified hydrosoluble 
fractions characterized onBiogel P 10 from delipidated mycobacetrial cells, strain H37Ra. 
Fractions Amino acids Amino sugars Reducing 
non-amino 
Ala Glu DAP GleN Mur sugars 
m.r. % m.r. % m.r. % m.r. % m.r. % % 
3.0 8.0 2.1 9.2 1.5 8.6 1.8 11.4 1.5 13.1 13±2 
3.0 8.5 2.3 10.7 1.5 8.9 1.5 10.3 2.0 15.3 11-12 
3.0 3.0 2.2 3.9 1.0 2.2 3.0 7.2 1.7 5.6 20.5 
3.0 0.9 3.4 1.8 0.3 0.2 3.3 2.6 0.5 0.5 
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however adjuvant-active [13, 25].  The biological 
properties of the different purified substances will 
be described in detail in a forthcoming paper [25]. 
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